REFERENCES
- Steinberg D, Parthasarathy S, Carew T E, Khoo J C, Witztum J L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915–924.
- Schwartz C J, Valente A J, Sprague E A. A modem view of atherogenesis. Am J Cardiol 1993; 71: 9B–14B.
- Berliner J A, Heinecke J W. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 1996; 20: 707–727.
- Navab M, Berliner J A, Watson A D, Hama S Y et al. The Yin and Yang of oxidation in the development of the fatty streak. Arterioscler Thromb Vase Biol 1996; 16: 831–842.
- Keaney J F, Frei B. Antioxidant protection of low density lipoprotein and its role in the prevention of atherosclerotic vascular disease. In: B. Frei ed. Natural Antioxidants in Human Health and Disease. San Diego: Academic Press, 1994: 303–351.
- Ylä-Herttuala S. Macrophages and oxidized low density lipoproteins in the pathogenesis of atherosclerosis. Annals Med 1991; 23: 561–567
- Brown M S, Goldstein J L. A receptor mediated pathway for cholesterol homeostasis. Science 1986; 232: 34–47.
- Retsky K L, Freeman M W, Frei B. Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification. Anti-rather than prooxidant activity of vitamin C in the presence of transition metal ions. J Biol Chem 1993; 268: 1304–1309.
- Retsky K L, Frei B. Vitamin C prevents metal ion-dependent initiation and propagation of lipid peroxidation in human low density lipoprotein. Biochim Biophys Acta 1995; 1257: 279–287.
- Kuzuya M, Yamada K, Hayashi T, Funaki C et al. Role of lipoprotein-copper complex in copper catalyzed-peroxidation of low-density lipoprotein. Biochim Biophys Acta 1992; 1123: 334–341.
- Chung B H, Segrest J P, Ray M J, Brunzell J D, et al. Single vertical spin density gradient ultracentrifugation. Methods Enzymol 1986; 128: 181–209.
- Lowry O H, Rosebrough N J, Farr A L, Randall R J. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265–275.
- Hunt J V, Wolff S P. The role of histidine residues in the nonenzymic covalent attachment of glucose and ascorbic acid to protein. Free Rad Res Commun 1991; 14: 279–287.
- Esterbauer H, Striegl G, Publ H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Commun 1989; 6: 67–75.
- Yamamoto Y, Frei B, Ames B N. Assay of lipid hydroperoxides using high-performance liquid chromatography with isoluminol chemiluminescence detection. Methods Enzymol 1990; 186: 371–380.
- Loosemore M J, Pratt R F. The irreversible cleavage of histidine residues by diethylpyrocarbonate (ethoxyformic anhydride). FEBS Lett 1976; 72: 155–158.
- Cladaras C, Hadzopoulou-Cladaras M, Nolte R T, Atkinson D et al. The complete sequence and structural analysis of human apolipoprotein B-100: relationship between apoB-100 and apoB-48 forms. EMBO J 1986; 5: 3495–3507.
- Gieseg S P, Esterbauer H. Low density lipoprotein is saturable by pro-oxidant copper. FEBS Lett 1994; 343: 188–194.
- Stadtman E R. Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. Annu Rev Biochem 1993; 62: 797–821.
- Lynch S M, Frei B. Reduction of copper, but not iron, by human low density lipoprotein (LDL). Implications for metal ion-dependent oxidative modification of LDL. J Biol Chem 1995; 270: 5158–5163.
- Waldeck A R, Stocker R. Radical-initiated lipid peroxidation in low density lipoproteins: insights obtained from kinetic modeling. Chem Res Toxicol 1996; 9: 954–964.